Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
- DOI
- 10.3389/fimmu.2021.622001
- Published
- 2021-03-02
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2021.622001,
title = {Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma},
author = {Roberta Sulsenti and Barbara Frossi and Lucia Bongiovanni and Valeria Cancila and Paola Ostano and Irene Fischetti and Claudia Enriquez and Francesca Guana and Giovanna Chiorino and Claudio Tripodo and Carlo E. Pucillo and Mario P. Colombo and Elena Jachetti},
year = {2021},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2021.622001},
url = {https://doi.org/10.3389/fimmu.2021.622001}
}RIS
TY - JOUR TI - Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma AU - Roberta Sulsenti AU - Barbara Frossi AU - Lucia Bongiovanni AU - Valeria Cancila AU - Paola Ostano AU - Irene Fischetti AU - Claudia Enriquez AU - Francesca Guana AU - Giovanna Chiorino AU - Claudio Tripodo AU - Carlo E. Pucillo AU - Mario P. Colombo AU - Elena Jachetti PY - 2021 JO - Frontiers in Immunology DO - 10.3389/fimmu.2021.622001 UR - https://doi.org/10.3389/fimmu.2021.622001 ER -
APA
Sulsenti, R., Frossi, B., Bongiovanni, L., Cancila, V., Ostano, P., Fischetti, I., Enriquez, C., Guana, F., Chiorino, G., Tripodo, C., Pucillo, C. E., Colombo, M. P., & Jachetti, E. (2021). Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.622001
Source records
- crossref · retrieved 2026-09-26T22:08:50.992Z